BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28625631)

  • 21. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
    Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
    Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cathepsins B, D and K in thymic epithelial tumours.
    Yamaguchi N; Tomaru U; Kiuchi T; Ishizu A; Deguchi T; Otsuka N; Tanaka S; Marukawa K; Matsuno Y; Kitagawa M; Kasahara M
    J Clin Pathol; 2021 Feb; 74(2):84-90. PubMed ID: 32467319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation between MMP-2 activation and MT1-MMP mRNA expression in thymic epithelial tumors].
    Wang Y; Ueda Y; Shimasaki M; Liu N; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):18-23. PubMed ID: 16608644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors.
    Sogawa K; Kondo K; Fujino H; Takahashi Y; Miyoshi T; Sakiyama S; Mukai K; Monden Y
    Cancer; 2003 Nov; 98(9):1822-9. PubMed ID: 14584061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of neurotrophin receptors in surgically resected thymic epithelial tumors.
    Kim DJ; Yang WI; Kim SH; Park IK; Chung KY
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):611-6. PubMed ID: 16125946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors.
    Breinig M; Mayer P; Harjung A; Goeppert B; Malz M; Penzel R; Neumann O; Hartmann A; Dienemann H; Giaccone G; Schirmacher P; Kern MA; Chiosis G; Rieker RJ
    Clin Cancer Res; 2011 Apr; 17(8):2237-49. PubMed ID: 21372220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
    Walts AE; Hiroshima K; Marchevsky AM
    Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour.
    Chang KC; Wu MH; Jones D; Chen FF; Tseng YL
    J Pathol; 2006 Oct; 210(2):224-33. PubMed ID: 16917804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.
    Nakagawa K; Matsuno Y; Kunitoh H; Maeshima A; Asamura H; Tsuchiya R
    Chest; 2005 Jul; 128(1):140-4. PubMed ID: 16002927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
    Fukumoto K; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Kato K; Matsuo K; Yokoi K
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
    Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka.
    Penzel R; Hoegel J; Schmitz W; Blaeker H; Morresi-Hauf A; Aulmann S; Hecker E; Mechtersheimer G; Otto HF; Rieker RJ
    Int J Cancer; 2003 Jul; 105(4):494-8. PubMed ID: 12712440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D2-40 Antibody is a Specific Marker for B2 Thymomas.
    Szolkowska M; Langfort R; Winiarski S; Rudzinski P; Giedronowicz D; Szczepulska-Wojcik E; Ronduda P; Maksymiuk B; Orlowski T
    Appl Immunohistochem Mol Morphol; 2017 Jul; 25(6):445-449. PubMed ID: 26808132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation ratio of MMP-2 and expression of MT1-MMP are correlated in thymic epithelial tumours.
    Wang Y; Xu HT; Ueda Y; Shimasaki M; Wang EH
    Pathology; 2007 Oct; 39(5):486-90. PubMed ID: 17886098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pax8 expression in thymic epithelial neoplasms: an immunohistochemical analysis.
    Weissferdt A; Moran CA
    Am J Surg Pathol; 2011 Sep; 35(9):1305-10. PubMed ID: 21836478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thymoma and thymic carcinoma--review of literature and clinical characteristics based on the Polish Paediatric Solid Tumours Study Group experience].
    Stachowicz-Stencel T; Bień E; Balcerska A; Godziński J; Madziara W; Perek-Polnik M; Peregud-Pogorzelski J; Pietras W; Pobudejska A; Kurylak A; Mańkowski P
    Med Wieku Rozwoj; 2007; 11(3 Pt 2):313-8. PubMed ID: 18663273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients.
    Liang N; Liu L; Huang C; Liu H; Guo C; Li J; Wang W; Li N; Lin R; Wang T; Ding L; Mao L; Li S
    Front Oncol; 2021; 11():647512. PubMed ID: 34568003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistological analysis of thymoma by molecules differentially expressed in the thymic cortex and medulla, and its application in the differential diagnosis of thymoma from esophageal and lung cancer.
    Shiraishi J; Utsuyama M; Akashi T; Nemoto T; Ohashi K; Akamatsu H; Sunamori M; Kitagawa M; Hirokawa K
    Pathol Res Pract; 2001; 197(9):611-9. PubMed ID: 11569925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant methylation of tumour-related genes in thymic epithelial tumours.
    Hirose Y; Kondo K; Takizawa H; Nagao T; Nakagawa Y; Fujino H; Toba H; Kenzaki K; Sakiyama S; Tangoku A
    Lung Cancer; 2009 May; 64(2):155-9. PubMed ID: 18778870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    J Surg Oncol; 2009 Jun; 99(7):433-8. PubMed ID: 19347882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.